Document ID: EPA-HQ-OARM-2018-0065-0007
Agency: epa
Document Type: Notice
Title: Agency Information Collection Activities; Proposals, Submissions, and Approvals: Drug Testing for Contractor Employees
Posted Date: 2021-07-23T04:00Z

[Federal Register Volume 86, Number 139 (Friday, July 23, 2021)]
[Notices]
[Page 39020]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-15640]

-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[EPA-HQ-OARM-2018-0065; FRL-8765-01-OMS]

Information Collection Request Submitted to OMB for Review and 
Approval; Comment Request; Drug Testing for Contractor Employees 
(Renewal)

AGENCY: Environmental Protection Agency (EPA).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Environmental Protection Agency (EPA) has submitted an 
information collection request (ICR), Drug Testing for Contractor 
Employees (EPA ICR No. 2183.08, OMB Control No. 2030-0044) to the 
Office of Management and Budget (OMB) for review and approval in 
accordance with the Paperwork Reduction Act. This is a proposed 
extension of the ICR, which is currently approved through September 30, 
2021. Public comments were previously requested via the Federal 
Register on March 8, 2021 during a 60-day comment period. This notice 
allows for an additional 30 days for public comments. A fuller 
description of the ICR is given below, including its estimated burden 
and cost to the public. An agency may not conduct or sponsor and a 
person is not required to respond to a collection of information unless 
it displays a currently valid OMB control number.

DATES: Additional comments may be submitted on or before August 23, 
2021.

ADDRESSES: Submit your comments, referencing Docket ID Number EPA-HQ-
OARM-2018-0065, online using www.regulations.gov (our preferred 
method), or by mail to: EPA Docket Center, Environmental Protection 
Agency, Mail Code 28221T, 1200 Pennsylvania Ave. NW, Washington, DC 
20460. EPA's policy is that all comments received will be included in 
the public docket without change including any personal information 
provided, unless the comment includes profanity, threats, information 
claimed to be Confidential Business Information (CBI), or other 
information whose disclosure is restricted by statute.
    Submit written comments and recommendations to OMB for the proposed 
information collection within 30 days of publication of this notice to 
www.reginfo.gov/public/do/PRAMain. Find this particular information 
collection by selecting ``Currently under 30-day Review--Open for 
Public Comments'' or by using the search function.

FOR FURTHER INFORMATION CONTACT: Thomas Valentino, Policy Training and 
Oversight Division, Office of Acquisition Solutions (3802R), 
Environmental Protection Agency, 1200 Pennsylvania Ave. NW, Washington, 
DC 20460; telephone number: (202) 564-4522; email address: 
valentino.thomas@epa.gov.

SUPPLEMENTARY INFORMATION: Supporting documents which explain in detail 
the information that the EPA will be collecting are available in the 
public docket for this ICR. The docket can be viewed online at 
www.regulations.gov or in person at the EPA Docket Center, WJC West, 
Room 3334, 1301 Constitution Ave. NW, Washington, DC. The telephone 
number for the Docket Center is 202-566-1744. For additional 
information about EPA's public docket, visit http://www.epa.gov/dockets.
    Abstract: This ICR applies to contractors who perform response 
services at sensitive sites with serious security concerns where the 
Agency and public interest would best be protected through drug 
testing. It requires the contractor to test its employees for the use 
of marijuana, cocaine, opiates, amphetamines, phencyclidine (PCP), and 
any other controlled substances. Only contractor employees who have 
been tested within the previous 90 calendar days and have passing drug 
test results may be directly engaged in on-site response work and/or 
on-site related activities at designated sites with significant 
security concerns. The Agency may request contractors responding to any 
of these types of incidents to conduct drug testing and apply 
Government-established suitability criteria in title 5 CFR 731.104, 
Appointments subject to investigation, 732.201, Sensitivity level 
designations and investigative requirements, and 736.102, Notice to 
investigative sources, when determining whether employees are 
acceptable to perform on given sites or on specific projects.
    Form numbers: None.
    Respondents/affected entities: Private contractors.
    Respondent's obligation to respond: Required to obtain a benefit 
per title 5 CFR 731.104.
    Estimated number of respondents: 500 (total).
    Frequency of response: Annual.
    Total estimated burden: 1,125 hours (per year). Burden is defined 
at 5 CFR 1320.03(b).
    Total estimated cost: $133,010 (per year), includes $0 annualized 
capital or operation & maintenance costs.
    Changes in estimates: There is no change in the hours in the total 
estimated respondent burden compared with the ICR currently approved by 
OMB.

Courtney Kerwin,
Director, Regulatory Support Division.
[FR Doc. 2021-15640 Filed 7-22-21; 8:45 am]
BILLING CODE 6560-50-P